Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
47.06
-0.15 (-0.32%)
Jun 27, 2025, 2:45 PM CST

Cathay Biotech Statistics

Total Valuation

Cathay Biotech has a market cap or net worth of CNY 33.33 billion. The enterprise value is 27.75 billion.

Market Cap 33.33B
Enterprise Value 27.75B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date Aug 14, 2025
Ex-Dividend Date Jul 24, 2024

Share Statistics

Cathay Biotech has 720.66 million shares outstanding. The number of shares has increased by 0.07% in one year.

Current Share Class 720.66M
Shares Outstanding 720.66M
Shares Change (YoY) +0.07%
Shares Change (QoQ) +3.87%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 17.77%
Float 251.86M

Valuation Ratios

The trailing PE ratio is 51.94 and the forward PE ratio is 65.14.

PE Ratio 51.94
Forward PE 65.14
PS Ratio 10.93
PB Ratio 1.58
P/TBV Ratio 1.98
P/FCF Ratio 999.97
P/OCF Ratio 48.09
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.17, with an EV/FCF ratio of 832.55.

EV / Earnings 53.30
EV / Sales 9.10
EV / EBITDA 38.17
EV / EBIT 68.76
EV / FCF 832.55

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.08.

Current Ratio 5.10
Quick Ratio 4.46
Debt / Equity 0.08
Debt / EBITDA 2.22
Debt / FCF 49.08
Interest Coverage 16.87

Financial Efficiency

Return on equity (ROE) is 2.73% and return on invested capital (ROIC) is 1.31%.

Return on Equity (ROE) 2.73%
Return on Assets (ROA) 1.19%
Return on Invested Capital (ROIC) 1.31%
Return on Capital Employed (ROCE) 1.87%
Revenue Per Employee 1.76M
Profits Per Employee 300,088
Employee Count 1,735
Asset Turnover 0.14
Inventory Turnover 1.69

Taxes

In the past 12 months, Cathay Biotech has paid 90.21 million in taxes.

Income Tax 90.21M
Effective Tax Rate 15.49%

Stock Price Statistics

The stock price has increased by +1.01% in the last 52 weeks. The beta is 0.62, so Cathay Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change +1.01%
50-Day Moving Average 49.35
200-Day Moving Average 45.43
Relative Strength Index (RSI) 43.90
Average Volume (20 Days) 2,063,788

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Cathay Biotech had revenue of CNY 3.05 billion and earned 520.65 million in profits. Earnings per share was 0.89.

Revenue 3.05B
Gross Profit 901.02M
Operating Income 413.47M
Pretax Income 582.26M
Net Income 520.65M
EBITDA 736.94M
EBIT 413.47M
Earnings Per Share (EPS) 0.89
Full Income Statement

Balance Sheet

The company has 10.80 billion in cash and 1.64 billion in debt, giving a net cash position of 9.16 billion or 12.71 per share.

Cash & Cash Equivalents 10.80B
Total Debt 1.64B
Net Cash 9.16B
Net Cash Per Share 12.71
Equity (Book Value) 21.15B
Book Value Per Share 29.50
Working Capital 10.41B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 693.14 million and capital expenditures -659.81 million, giving a free cash flow of 33.33 million.

Operating Cash Flow 693.14M
Capital Expenditures -659.81M
Free Cash Flow 33.33M
FCF Per Share 0.05
Full Cash Flow Statement

Margins

Gross margin is 29.55%, with operating and profit margins of 13.56% and 17.08%.

Gross Margin 29.55%
Operating Margin 13.56%
Pretax Margin 19.10%
Profit Margin 17.08%
EBITDA Margin 24.17%
EBIT Margin 13.56%
FCF Margin 1.09%

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.84%.

Dividend Per Share 0.40
Dividend Yield 0.84%
Dividend Growth (YoY) 5.56%
Years of Dividend Growth 1
Payout Ratio 27.48%
Buyback Yield -0.07%
Shareholder Yield 0.79%
Earnings Yield 1.56%
FCF Yield 0.10%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.

Last Split Date Jul 20, 2022
Split Type Forward
Split Ratio 1.4

Scores

Cathay Biotech has an Altman Z-Score of 5.14 and a Piotroski F-Score of 7.

Altman Z-Score 5.14
Piotroski F-Score 7